Monika Kozak Ljunggren1, Rodolfo A Elizondo1, Elle Edin1, David Olsen2, Kimberley Merrett3, Chyan-Jang Lee3, Göran Salerud4, James Polarek2, Per Fagerholm1, May Griffith3. 1. Integrative Regenerative Medicine Centre and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. 2. FibroGen Incorporated, San Francisco, CA, USA. 3. Integrative Regenerative Medicine Centre and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden ; Ottawa Hospital Research Institute-Vision Programme, Ottawa, Ontario, Canada. 4. Integrative Regenerative Medicine Centre and Department of Biomedical Engineering, Linköping University, Linköping, Sweden.
Abstract
PURPOSE: Our aim was to determine the effect of a surgical technique on biomaterial implant performance, specifically graft retention. METHODS: Twelve mini pigs were implanted with cell-free, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) cross-linked recombinant human collagen type III (RHCIII) hydrogels as substitutes for donor corneal allografts using overlying sutures with or without human amniotic membrane (HAM) versus interrupted sutures with HAM. The effects of the retention method were compared as well as the effects of collagen concentration (13.7% to 15% RHCIII). RESULTS: All implanted corneas showed initial haze that cleared with time, resulting in corneas with optical clarity matching those of untreated controls. Biochemical analysis showed that by 12 months post operation, the initial RHCIII implants had been completely remodeled, as type I collagen, was the major collagenous protein detected, whereas no RHCIII could be detected. Histological analysis showed all implanted corneas exhibited regeneration of epithelial and stromal layers as well as nerves, along with touch sensitivity and tear production. Most neovascularization was seen in corneas stabilized by interrupted sutures. CONCLUSIONS: This showed that the surgical technique used does have a significant effect on the overall performance of corneal implants, overlying sutures caused less vascularization than interrupted sutures. TRANSLATIONAL RELEVANCE: Understanding the significance of the suturing technique can aid the selection of the most appropriate procedure when implanting artificial corneal substitutes. The same degree of regeneration, despite a higher collagen content indicates that future material development can progress toward stronger, more resistant implants.
PURPOSE: Our aim was to determine the effect of a surgical technique on biomaterial implant performance, specifically graft retention. METHODS: Twelve mini pigs were implanted with cell-free, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) cross-linked recombinant human collagen type III (RHCIII) hydrogels as substitutes for donor corneal allografts using overlying sutures with or without human amniotic membrane (HAM) versus interrupted sutures with HAM. The effects of the retention method were compared as well as the effects of collagen concentration (13.7% to 15% RHCIII). RESULTS: All implanted corneas showed initial haze that cleared with time, resulting in corneas with optical clarity matching those of untreated controls. Biochemical analysis showed that by 12 months post operation, the initial RHCIII implants had been completely remodeled, as type I collagen, was the major collagenous protein detected, whereas no RHCIII could be detected. Histological analysis showed all implanted corneas exhibited regeneration of epithelial and stromal layers as well as nerves, along with touch sensitivity and tear production. Most neovascularization was seen in corneas stabilized by interrupted sutures. CONCLUSIONS: This showed that the surgical technique used does have a significant effect on the overall performance of corneal implants, overlying sutures caused less vascularization than interrupted sutures. TRANSLATIONAL RELEVANCE: Understanding the significance of the suturing technique can aid the selection of the most appropriate procedure when implanting artificial corneal substitutes. The same degree of regeneration, despite a higher collagen content indicates that future material development can progress toward stronger, more resistant implants.
Authors: Kimberley Merrett; Per Fagerholm; Christopher R McLaughlin; Subhadra Dravida; Neil Lagali; Naoshi Shinozaki; Mitchell A Watsky; Rejean Munger; Yasuhiro Kato; Fengfu Li; Christopher J Marmo; May Griffith Journal: Invest Ophthalmol Vis Sci Date: 2008-05-30 Impact factor: 4.799
Authors: Sharon Altmann; Andrew Emanuel; Megan Toomey; Kim McIntyre; Jill Covert; Richard Redd Dubielzig; Gary Leatherberry; Christopher J Murphy; Shantha Kodihalli; Curtis R Brandt Journal: Invest Ophthalmol Vis Sci Date: 2010-04-07 Impact factor: 4.799
Authors: M Mirazul Islam; Oleksiy Buznyk; Jagadesh C Reddy; Nataliya Pasyechnikova; Keith M Meek; Virender S Sangwan; May Griffith; Emilio I Alarcon; Sally Hayes; Philip Lewis; Per Fagerholm; Chaoliang He; Stanislav Iakymenko; Wenguang Liu Journal: NPJ Regen Med Date: 2018-01-31
Authors: Jaganmohan R Jangamreddy; Michel K C Haagdorens; M Mirazul Islam; Philip Lewis; Ayan Samanta; Per Fagerholm; Aneta Liszka; Monika K Ljunggren; Oleksiy Buznyk; Emilio I Alarcon; Nadia Zakaria; Keith M Meek; May Griffith Journal: Acta Biomater Date: 2018-01-31 Impact factor: 8.947
Authors: Christopher D McTiernan; Fiona C Simpson; Michel Haagdorens; Chameen Samarawickrama; Damien Hunter; Oleksiy Buznyk; Per Fagerholm; Monika K Ljunggren; Philip Lewis; Isabel Pintelon; David Olsen; Elle Edin; Marc Groleau; Bruce D Allan; May Griffith Journal: Sci Adv Date: 2020-06-17 Impact factor: 14.136
Authors: Lingjia Liu; Wenbo Cheng; Di Wu; Luxia Chen; Shasha Yu; Tong Zuo; Lin Zhang; Kun Yang; Hua Li; Hui Zhang; Pinghui Wei; Alex Lap Ki Ng; George Pak-Man Cheng; Victor Chi-Pang Woo; Jia Yin; Kin Chiu; Yan Wang Journal: Invest Ophthalmol Vis Sci Date: 2020-05-11 Impact factor: 4.799
Authors: Susanne G Pondorfer; Maximilian W M Wintergerst; Shekoufeh Gorgi Zadeh; Thomas Schultz; Manuel Heinemann; Frank G Holz; Robert P Finger Journal: Invest Ophthalmol Vis Sci Date: 2020-03-09 Impact factor: 4.799